Piramal Pharma Limited Announces Results for Q1FY26
MUMBAI, India, July 28, 2025 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, and health and wellness company, today announced its standalone and consolidated results for the First Quarter (Q1) ended 30th June 2025. Consolidated Financial Highlights (in ₹ Crores or as stated) Particulars Q1FY26 Q1FY25 YoY Growth Revenue from […]
Piramal Pharma Limited Announces Results for Q1FY26 Read Post »
Press




